Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 5,263,514 |
|
|||||
| News | (1) | ||||||
| Day High | 11.69 | Low High |
|||||
| Day Low | 11.01 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.44 | -3.75% | 11.28 | 18:02:21 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.60 | 11.01 | 11.69 | 11.31 | 11.72 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 37,030 | 5,263,514 | $ 11.34 | $ 59,702,118 | - | 3.21 - 18.33 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:24:29 | 1 | $ 11.26 | USD |
Iovance Biotherapeutics (IOVA) Options Flow Summary
Iovance Biotherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.16B | 279.31M | - | 1.19M | -444.04M | -1.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 13.01 | 13.13 | 11.01 | 11.95 | 4,623,085 | -1.73 | -13.30% |
| 1 Month | 15.234 | 15.50 | 11.01 | 13.33 | 4,558,778 | -3.95 | -25.96% |
| 3 Months | 7.70 | 18.33 | 7.34 | 13.71 | 9,361,278 | 3.58 | 46.49% |
| 6 Months | 3.29 | 18.33 | 3.21 | 10.27 | 8,392,382 | 7.99 | 242.86% |
| 1 Year | 5.62 | 18.33 | 3.21 | 8.77 | 7,158,671 | 5.66 | 100.71% |
| 3 Years | 29.60 | 33.55 | 3.21 | 10.72 | 4,444,025 | -18.32 | -61.89% |
| 5 Years | 10.75 | 54.2081 | 3.21 | 14.33 | 3,304,528 | 0.53 | 4.93% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes to treat patients with refractory metastatic melanoma. |
